| 000 | 01616 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518011511.0 | ||
| 264 | 0 | _c20190807 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1938-0682 | ||
| 024 | 7 |
_a10.1016/j.clgc.2018.09.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoyce, Trevor J | |
| 245 | 0 | 0 |
_aComparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer. _h[electronic resource] |
| 260 |
_bClinical genitourinary cancer _cFeb 2019 |
||
| 300 |
_a23-31.e3 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCombined Modality Therapy _xmortality |
| 650 | 0 | 4 | _aComparative Effectiveness Research |
| 650 | 0 | 4 |
_aCystectomy _xmortality |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscle Neoplasms _xmortality |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 |
_aOrgan Sparing Treatments _xmortality |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xmortality |
| 700 | 1 | _aFeldman, Adam S | |
| 700 | 1 | _aMossanen, Matthew | |
| 700 | 1 | _aYang, Joanna C | |
| 700 | 1 | _aShipley, William U | |
| 700 | 1 | _aPandharipande, Pari V | |
| 700 | 1 | _aEfstathiou, Jason A | |
| 773 | 0 |
_tClinical genitourinary cancer _gvol. 17 _gno. 1 _gp. 23-31.e3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clgc.2018.09.023 _zAvailable from publisher's website |
| 999 |
_c29096869 _d29096869 |
||